Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies
Schneeweiss A, Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Ettl J, Belleville E, Huober J, Thill M, Fasching P, Kolberg HC, Pöschke P, Welslau M, Overkamp F, Tesch H, Fehm TN, Lueftner D, Schuetz F (2020)
Publication Type: Journal article, Review article
Publication year: 2020
Journal
Book Volume: 80
Pages Range: 277-287
Journal Issue: 3
DOI: 10.1055/a-1111-2431
Abstract
This review is intended to present the latest developments in the prevention and treatment of early breast cancer. The risk of breast cancer can be increasingly better characterised with large epidemiological studies on genetic and non-genetic risk factors. Through new analyses, the evidence for high-penetrance genes as well as for low-penetrance genes was able to be improved. New data on denosumab and atezolizumab are available in the neoadjuvant situation as is a pooled appraisal of numerous studies on capecitabine in the curative situation. There is also an update to the overall survival data of pertuzumab in the adjuvant situation with a longer follow-up observation period. Finally, digital medicine is steadily finding its way into science. A recently conducted study on automated breast cancer detection using artificial intelligence establishes the basis for a future review in clinical studies.
Authors with CRIS profile
Peter Fasching
Professur für Translationale Frauenheilkunde und Geburtshilfe
Patrik Pöschke
Medizinische Fakultät
Involved external institutions
Universitätsklinikum Würzburg
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Agaplesion Markus Krankenhaus
Germany (DE)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
Marienhospital Bottrop
Germany (DE)
ClinSol GmbH & Co.KG
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Frauen- und Kinderklinik St. Louise
Germany (DE)
Technische Universität München (TUM)
Germany (DE)
Eberhard Karls Universität Tübingen
Germany (DE)
Universitätsklinikum Düsseldorf
Germany (DE)
Ruprecht-Karls-Universität Heidelberg
Germany (DE)
Centrum für Hämatologie und Onkologie Bethanien
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Agaplesion Markus Krankenhaus
Germany (DE)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
Marienhospital Bottrop
Germany (DE)
ClinSol GmbH & Co.KG
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Frauen- und Kinderklinik St. Louise
Germany (DE)
Technische Universität München (TUM)
Germany (DE)
Eberhard Karls Universität Tübingen
Germany (DE)
Universitätsklinikum Düsseldorf
Germany (DE)
Ruprecht-Karls-Universität Heidelberg
Germany (DE)
Centrum für Hämatologie und Onkologie Bethanien
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
How to cite
APA:
Schneeweiss, A., Hartkopf, A.D., Mueller, V., Woeckel, A., Lux, M.P., Janni, W.,... Schuetz, F. (2020). Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies. Geburtshilfe und Frauenheilkunde, 80(3), 277-287. https://doi.org/10.1055/a-1111-2431
MLA:
Schneeweiss, Andreas, et al. "Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies." Geburtshilfe und Frauenheilkunde 80.3 (2020): 277-287.
BibTeX: Download